Warrenton, Virginia
United States
20
2025-09-30
20
2025-09-30
These are the the leading inventors for applications assigned to MicroVAX, LLC:
MicroVAX, LLC based in Warrenton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
SARS-CoV-2 fusion protein vaccine/regimen
#2 | 2021-10-26 ✅ Patent 11,154,603 granted on 2021-10-26Burkholderia pseudomallei composition
#3 | 2020-02-13 ✅ Patent 10,835,589 granted on 2020-11-17Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD40L/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells
#4 | 2019-10-01 ✅ Patent 10,426,827 granted on 2019-10-01Dengue hemorrhagic fever virus vaccine
#5 | 2019-05-21 ✅ Patent 10,293,040 granted on 2019-05-21Pharmaceutical compositions and methods of blocking
#6 | 2019-03-07 ✅ Patent 11,839,655 granted on 2023-12-12Combination cancer therapy
#7 | 2019-01-22 ✅ Patent 10,183,067 granted on 2019-01-22TAA/CD4OL composition/vaccine for malaria
#8 | 2019-01-08 ✅ Patent 10,174,100 granted on 2019-01-08Multivalent DNA composition for
#9 | 2019-01-01 ✅ Patent 10,166,284 granted on 2019-01-01Vaccines for herpes simplex virus 1 and 2
#10 | 2018-12-11 ✅ Patent 10,149,899 granted on 2018-12-11Composition and method against C-difficile
#11 | 2018-11-20 ✅ Patent 10,130,667 granted on 2018-11-20TAA/ecdCD40L oncolytic virus
#12 | 2018-02-13 ✅ Patent 9,889,188 granted on 2018-02-13Ebola virus composition/vaccine
#13 | 2017-08-24 ✅ Patent 10,383,932 granted on 2019-08-20Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells
#14 | 2017-06-29 ✅ Patent 11,077,183 granted on 2021-08-03CD40 ligand fusion protein vaccine
#15 | 2017-06-29 ✅ Patent 10,046,041 granted on 2018-08-14Methods and compositions for suppressing virulence of methicillin resistant
#16 | 2017-01-19 ✅ Patent 9,757,438 granted on 2017-09-12Mucin antigen vaccine
#17 | 2016-12-27 ✅ Patent 9,526,774 granted on 2016-12-27Methods and compositions for suppressing virulence of methicillin resistant
#18 | 2015-03-05 ✅ Patent 9,353,167 granted on 2016-05-31Methods for generating immunity to antigen
#19 | 2014-10-30 ✅ Patent 9,402,920 granted on 2016-08-02Mucin antigen vaccine
#20 | 2007-06-07 ✅ Patent 9,533,036 granted on 2017-01-03Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein
Also check out MicroVAX, LLC's (Warrenton, United States) applicant profile with 10 patent applications submitted.
508412 ⎘